nygazet.com logo
New hormone protocol cut relapse risk in prostate cancer trial
business

New hormone protocol cut relapse risk in prostate cancer trial

1 min read

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

CHICAGO — Patients with high risk prostate cancer that hasn’t spread typically have two standard treatment paths before them. Remove the prostate surgically, or do a combination of radiation therapy and hormone therapy. Now, with the results of a new... [393 chars]

Read Original Article

Source: statnews.com

Visit Source

Share this article